A hypothesis: Can erythropoietin administration affect the severity of retinopathy in diabetic patients with renal failure?

American Journal of the Medical Sciences

Volumn 334, Issue 4, 2007, Pages 260-264

  Diskin, Charles J ^a   Stokes, Thomas J ^a   Dansby, Linda M ^a   Radcliff, Lautrec ^a   Carter, Thomas B ^a  

^a AUBURN UNIVERSITY   (United States)

Author keywords

Angiogenesis; Diabetes; Erythropoietin; Hemodialysis; Retinopathy; Vascular complications

Indexed keywords

CHOLESTEROL; RECOMBINANT ERYTHROPOIETIN; ERYTHROPOIETIN;

ADULT; CHOLESTEROL BLOOD LEVEL; CHRONIC KIDNEY FAILURE; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; CORRELATION ANALYSIS; CORRELATION COEFFICIENT; DETERIORATION; DIABETES MELLITUS; DIABETIC NEUROPATHY; DIABETIC PATIENT; DIABETIC RETINOPATHY; DIALYSIS; DISEASE COURSE; DISEASE DURATION; DISEASE SEVERITY; DRUG BIOAVAILABILITY; FEMALE; HEMATOCRIT; HEMODIALYSIS; HUMAN; HYPERTENSION; MALE; MEDICAL RECORD REVIEW; MULTIVARIATE ANALYSIS; OPHTHALMOSCOPY; PREVALENCE; REVIEW; RISK FACTOR; STATISTICAL SIGNIFICANCE; ANEMIA; ARTICLE; BLOOD; BLOOD PRESSURE; CASE CONTROL STUDY; CHEMICALLY INDUCED DISORDER; DOSE RESPONSE; GLUCOSE BLOOD LEVEL; HOSPITALIZATION; METABOLISM; MIDDLE AGED; PATHOPHYSIOLOGY; PHYSIOLOGY; RENAL REPLACEMENT THERAPY; RETROSPECTIVE STUDY;

ANEMIA; BLOOD GLUCOSE; BLOOD PRESSURE; CASE-CONTROL STUDIES; CHOLESTEROL; DIABETIC RETINOPATHY; DISEASE PROGRESSION; DOSE-RESPONSE RELATIONSHIP, DRUG; ERYTHROPOIETIN; FEMALE; HUMANS; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PREVALENCE; RENAL DIALYSIS; RETROSPECTIVE STUDIES; RISK FACTORS; SEVERITY OF ILLNESS INDEX;

EID: 38449103363     PISSN: 00029629     EISSN: None     Source Type: Journal    
DOI: 10.1097/MAJ.0b013e3180a5e8ed     Document Type: Article

References (20)

1. MacEwen C.J. Barrie T. Junor B.J. The visual status of diabetics on renal replacement therapy (RRT) Eye 1 Pt 3 1987 379 385
2. Watanabe Y. Yuzawa Y. Mizumoto D. Long-term follow-up study of 268 diabetic patients undergoing haemodialysis, with special attention to visual acuity and heterogeneity Nephrol Dial Transplant 8 1993 725 734
3. Tokuyama T. Ikeda T. Sato K. Effects of haemodialysis on diabetic macular leakage Br J Ophthalmol 84 2000 1397 1400
4. Watanabe D. Suzuma K. Matsui S. Erythropoietin as a retinal angiogenic factor in proliferative diabetic retinopathy N Engl J Med 353 2005 782 792
5. Sinclair S.H. DelVecchio C. Levin A. Treatment of anemia in the diabetic patient with retinopathy and kidney disease Am J Ophthalmol 135 2003 740 743
6. Friedman E.A. Brown C.D. Berman D.H. Erythropoietin in diabetic macular edema and renal insufficiency Am J Kidney Dis 26 1995 202 208
7. Wilkinson C.P. Ferris F.L. 3rd Klein R.E. Global Diabetic Retinopathy Project Group: proposed international clinical diabetic retinopathy and diabetic macular edema disease severity scales Ophthalmology 110 2003 1677 1682
8. Delanty N. Needell N. Erythropoietin and visual hallucinations in patients on dialysis Psychosomatics 39 1998 83 85
9. Jacquot C. Berthelot J.M. Chiappini-Judith D. Treatment of anemia in chronic hemodialysis patients with recombinant human erythropoietin: long-term results in 15 patients Nephrologie 11 1990 11 16
10. Davis M.D. Fisher M.R. Gangnon R.E. Risk factors for high-risk proliferative diabetic retinopathy and severe visual loss: Early Treatment Diabetic Retinopathy Study Report #18 Invest Ophthalmol Vis Sci 39 1998 233 252
11. Qiao Q. Keinanen-Kiukaanniemi S. Laara E. The relationship between hemoglobin levels and diabetic retinopathy J Clin Epidemiol 50 1997 153 158
12. Diskin C.J. Stokes T.J. Dansby L.M. Can acidosis and hyperphosphataemia result in increased erythropoietin dosing in haemodialysis patients? Nephrology (Carlton) 11 2006 394 399
13. Diskin C.J. Hitting the target but missing the goal? Hemoglobin targets vs oxygen delivery Am J Kidney Dis 50 2007 344
14. Diskin C.J. Jones K.L.O. Erythropoietin levels in ESRD by enzyme immunoassay. Abstract ASN 1984 62
15. Diskin C.J. Jones K.L.O. Erythropoietin levels in ESRD by enzyme immunoassay. Abstract Kidney Int 27 1985 160A
16. Diskin C.J. Erythropoietin levels and androgens use: what is their relationship in the correction of anemia? Arch Intern Med 167 2007 309
17. Nurko S. Anemia in chronic kidney disease: causes, diagnosis, treatment Cleve Clin J Med 73 2006 289 297
18. th edition. 1996 Mosby Publishers St. Louis, MO 509 514
19. Zander E. Herfurth S. Bohl B. Maculopathy in patients with diabetes mellitus type 1 and type 2: associations with risk factors Br J Ophthalmol 84 2000 871 876
20. Emanuele N. Sacks J. Klein R. Veterans Affairs Diabetes Trial Group: ethnicity, race, and baseline retinopathy correlates in the veterans’ affairs diabetes trial Diabetes Care 28 2005 1954 1958